ArticleCirculation2018
Evidence for Minimal Cardiogenic Potential of Stem Cell Antigen 1-Positive Cells in the Adult Mouse Heart.
Abstract readLetter
In one paragraph
Article in Circulation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Pluripotent stem cell-based approaches for heart repair and the potential of genetic modifications.Molecular therapy : the journal of the American Society of Gene Therapy · 2025Review
- Reprogramming of human urine cells into cardiomyocytes via a small molecule cocktail in xeno-free conditions.Communications medicine · 2025Article
- Recent Insights into Endogenous Mammalian Cardiac Regeneration Post-Myocardial Infarction.International journal of molecular sciences · 2024Review
- Unravelling the Interplay between Cardiac Metabolism and Heart Regeneration.International journal of molecular sciences · 2023Review
- Metabolic Determinants in Cardiomyocyte Function and Heart Regenerative Strategies.Metabolites · 2022Review
- Reprogramming of fibroblasts into expandable cardiovascular progenitor cells via small molecules in xeno-free conditions.Nature biomedical engineering · 2022Article
- Heart regeneration: 20 years of progress and renewed optimism.Developmental cell · 2022Review
- Cardiac regeneration: Options for repairing the injured heart.Frontiers in cardiovascular medicine · 2022Review
- Non-coding RNAs in cardiac regeneration: Mechanism of action and therapeutic potential.Seminars in cell & developmental biology · 2021Review
- In vitro CSC-derived cardiomyocytes exhibit the typical microRNA-mRNA blueprint of endogenous cardiomyocytes.Communications biology · 2021Article
- Stem cell therapies in cardiac diseases: Current status and future possibilities.World journal of stem cells · 2021Review
- Cardiac Cell Therapy: Insights into the Mechanisms of Tissue Repair.International journal of molecular sciences · 2021Review
- Novel Insights Linking lncRNAs and Metabolism With Implications for Cardiac Regeneration.Frontiers in physiology · 2021Review
- Single-cell gene profiling and lineage tracing analyses revealed novel mechanisms of endothelial repair by progenitors.Cellular and molecular life sciences : CMLS · 2020Article
- Myocardial Infarction Does Not Accelerate Atherosclerosis in a Mouse Model of Type 1 Diabetes.Diabetes · 2020Article
- The Role of TGF-β Signaling in Cardiomyocyte Proliferation.Current heart failure reports · 2020Review
- Arrhythmogenic risks of stem cell replacement therapy for cardiovascular diseases.Journal of cellular physiology · 2020Review
- Heart Regeneration by Endogenous Stem Cells and Cardiomyocyte Proliferation: Controversy, Fallacy, and Progress.Circulation · 2020Article
- Cardioprotective Potential of Human Endothelial-Colony Forming Cells from Diabetic and Nondiabetic Donors.Cells · 2020Article
- Hematopoietic Stem Cell Transcription Factors in Cardiovascular Pathology.Frontiers in genetics · 2020Review
Corrections and comments
- Commented on by
Authors and funding
13 authors.
Lauren E NeidigDepartment of Pathology (L.E.N., F.W., N.J.P., A.M.M., H.R., L.P., C.E.M.), University of Washington, Seattle.
Florian WeinbergerDepartment of Pathology (L.E.N., F.W., N.J.P., A.M.M., H.R., L.P., C.E.M.), University of Washington, Seattle.
Nathan J PalpantDepartment of Pathology (L.E.N., F.W., N.J.P., A.M.M., H.R., L.P., C.E.M.), University of Washington, Seattle.
John MignoneInstitute for Stem Cell and Regenerative Medicine (L.E.N., F.W., N.J.P., J.M., A.M.M., H.R., L.P., C.E.M.), University of Washington, Seattle.
Amy M MartinsonDepartment of Pathology (L.E.N., F.W., N.J.P., A.M.M., H.R., L.P., C.E.M.), University of Washington, Seattle.
Daniel W SorensenStem Cell Institute and Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis (D.W.S., I.B., N.N., J.H.v.B.).
Ingrid BenderStem Cell Institute and Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis (D.W.S., I.B., N.N., J.H.v.B.).
Natsumi NemotoStem Cell Institute and Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis (D.W.S., I.B., N.N., J.H.v.B.).
Hans ReineckeDepartment of Pathology (L.E.N., F.W., N.J.P., A.M.M., H.R., L.P., C.E.M.), University of Washington, Seattle.
Lil PabonDepartment of Pathology (L.E.N., F.W., N.J.P., A.M.M., H.R., L.P., C.E.M.), University of Washington, Seattle.
Jeffery D MolkentinDepartment of Pediatrics, Howard Hughes Medical Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, OH (J.D.M.).
Charles E MurryDepartment of Pathology (L.E.N., F.W., N.J.P., A.M.M., H.R., L.P., C.E.M.), University of Washington, Seattle.
Jop H van BerloStem Cell Institute and Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis (D.W.S., I.B., N.N., J.H.v.B.).
Funding
Vascularization and Growth of Human Myocardial GraftsP01HL094374 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E · 2010 to 2014
$14.5MPrimate Heart RegenerationR01HL128362 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E · 2016 to 2019
$3.5MStrategic activation of endogenous c-kit+ progenitor cells for cardiac regenerationR01HL130072 · NHLBI · UNIVERSITY OF MINNESOTA · PI VAN BERLO, JOHANNES (JOP) · 2016 to 2020
$1.9MFunctional relevance of cardiac regeneration by c-kit positive stem cellsR00HL112852 · NHLBI · UNIVERSITY OF MINNESOTA · PI VAN BERLO, JOHANNES (JOP) · 2013 to 2015
$712kStem Cell Biology Training ProgramT32GM113846 · NIGMS · UNIVERSITY OF MINNESOTA · PI PERLINGEIRO, RITA C. R. · 2015 to 2019
$712kNHLBI NIH HHS P01 HL094374NHLBI NIH HHS R00 HL112852NHLBI NIH HHS R01 HL128362NHLBI NIH HHS R01 HL130072NIGMS NIH HHS T32 GM113846
Abstract
PubMed holds no abstract for this paper.
Indexed as
Adult Stem CellsAnimalsAntigens, LyCell DifferentiationCell LineageCells, CulturedCell Self RenewalEndothelial CellsHumansMembrane ProteinsMiceMice, TransgenicModels, AnimalMuscle DevelopmentMyocardial InfarctionMyocytes, CardiacAntigens, LyLy6a protein, mouseMembrane ProteinsTamoxifenheart failuremyocardial infarctionprogenitor cellsregeneration
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.